Literature DB >> 26954296

Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.

Esther Roura, Noémie Travier, Tim Waterboer, Silvia de Sanjosé, F Xavier Bosch, Michael Pawlita, Valeria Pala, Elisabete Weiderpass, Núria Margall, Joakim Dillner, Inger T Gram, Anne Tjønneland, Christian Munk, Domenico Palli, Kay-Tee Khaw, Kim Overvad, Françoise Clavel-Chapelon, Sylvie Mesrine, Agnès Fournier, Renée T Fortner, Jennifer Ose, Annika Steffen, Antonia Trichopoulou, Pagona Lagiou, Philippos Orfanos, Giovanna Masala, Rosario Tumino, Carlotta Sacerdote, Silvia Polidoro, Amalia Mattiello, Eiliv Lund, Petra H Peeters, H B As Bueno-de-Mesquita, J Ramón Quirós, María-José Sánchez, Carmen Navarro, Aurelio Barricarte, Nerea Larrañaga, Johanna Ekström, David Lindquist, Annika Idahl, Ruth C Travis, Melissa A Merritt, Marc J Gunter, Sabina Rinaldi, Massimo Tommasino, Silvia Franceschi, Elio Riboli, Xavier Castellsagué.   

Abstract

Entities:  

Year:  2016        PMID: 26954296      PMCID: PMC4783099          DOI: 10.1371/journal.pone.0151427

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
There are errors in the Funding section. The complete, correct Funding section is as follows: The work was partially supported by grants from the Instituto de Salud Carlos III (Spanish Government) (grants FIS PI08/1308, FIS PI11/02096, PI13/00053, RCESP C03/09, RTICESP C03/10, RTIC RD06/0020/0095, RD12/0036/0056, RD12/0036/0018, and CIBERESP) and from the Agència de Gestió d'Ajuts Universitaris i de Recerca—Generalitat de Catalunya (Catalonian Government) (grants AGAUR 2005SGR00695, 2009SGR939 and 2009SGR126, 2014SGR1077, 2014SGR756, 2014SGR2016), European Regional Development fund (FEDER) "A way to build Europe". The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by the Health Research Fund (FIS) of the Spanish Ministry of Health (Exp P10710130), Regional Governments of Andalucía, Asturias, Basque Country, Murcia (no. 6236), Navarra and the Catalan Institute of Oncology, La Caixa (BM 06–130), RTICC-RD06/10091 (Spain); Danish Cancer Society (Denmark); Ligue contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, Institut National de la Santé et de la Recherche Médicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF) and Statistics Netherlands (The Netherlands); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skåne and Västerbotten (Sweden); Cancer Research UK, Medical Research Council (United Kingdom); Norwegian Research Council, Norwegian Cancer Society, University of Tromso (Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
  1 in total

1.  The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.

Authors:  Esther Roura; Noémie Travier; Tim Waterboer; Silvia de Sanjosé; F Xavier Bosch; Michael Pawlita; Valeria Pala; Elisabete Weiderpass; Núria Margall; Joakim Dillner; Inger T Gram; Anne Tjønneland; Christian Munk; Domenico Palli; Kay-Tee Khaw; Kim Overvad; Françoise Clavel-Chapelon; Sylvie Mesrine; Agnès Fournier; Renée T Fortner; Jennifer Ose; Annika Steffen; Antonia Trichopoulou; Pagona Lagiou; Philippos Orfanos; Giovanna Masala; Rosario Tumino; Carlotta Sacerdote; Silvia Polidoro; Amalia Mattiello; Eiliv Lund; Petra H Peeters; H B as Bueno-de-Mesquita; J Ramón Quirós; María-José Sánchez; Carmen Navarro; Aurelio Barricarte; Nerea Larrañaga; Johanna Ekström; David Lindquist; Annika Idahl; Ruth C Travis; Melissa A Merritt; Marc J Gunter; Sabina Rinaldi; Massimo Tommasino; Silvia Franceschi; Elio Riboli; Xavier Castellsagué
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  1 in total
  4 in total

1.  A prospective cohort study of oral contraceptive use and ovarian cancer among women in the United States born from 1947 to 1964.

Authors:  Amy L Shafrir; Helena Schock; Elizabeth M Poole; Kathryn L Terry; Rulla M Tamimi; Susan E Hankinson; Bernard A Rosner; Shelley S Tworoger
Journal:  Cancer Causes Control       Date:  2017-03-13       Impact factor: 2.506

Review 2.  Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research.

Authors:  Jennifer A Doherty; Allan Jensen; Linda E Kelemen; Celeste L Pearce; Elizabeth Poole; Joellen M Schildkraut; Kathryn L Terry; Shelley S Tworoger; Penelope M Webb; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2017-10-01       Impact factor: 13.506

3.  Women's perception of cervical cancer pap smear screening.

Authors:  Kristine N Siseho; Beauty Etinosa Omoruyi; Benjamin I Okeleye; Vincent I Okudoh; Hans J Amukugo; Yapo G Aboua
Journal:  Nurs Open       Date:  2022-03-04

4.  Telomerase activity in cervical scrapes of women with high-grade cervical disease: A nested case-control study.

Authors:  Mónica Molano; Diana Carolina Martín; Pablo Moreno-Acosta; Gustavo Hernández; Alyssa Cornall; Oscar Buitrago; Oscar Gamboa; Suzanne Garland; Sepehr Tabrizi; Nubia Muñoz
Journal:  Oncol Lett       Date:  2017-11-01       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.